has been cited by the following article(s):
|
[1]
|
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
|
|
Agudelo, R Romero - Journal of Perinatal Medicine,
2023 |
|
|
|
|
[2]
|
Nursing Care for Pregnant Women at Risk of Preterm Labor and Its Impact on Pregnancy Outcomes
|
|
Minia Scientific …,
2023 |
|
|
|
|
[3]
|
Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical …
|
|
Agudelo, R Romero - American Journal of Obstetrics & …,
2022 |
|
|
|
|
[4]
|
ผล ของ การ ใช้ ยา โปร เจ ส เต อ โร น แบบ เหน็บ ทาง ช่อง คลอด ต่อ การ ป้องกัน การ คลอด ก่อน กำหนด ใน หญิง ตั้ง ครรภ์ ที่ เคย คลอด ก่อน กำหนด
|
|
The Journal of Prapokklao Hospital Clinical …,
2022 |
|
|
|
|
[5]
|
Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester …
|
|
Agudelo, R Romero - American journal of obstetrics and …,
2022 |
|
|
|
|
[6]
|
Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a …
|
|
Agudelo, R Romero - American Journal of Obstetrics and …,
2022 |
|
|
|
|
[7]
|
The Efficacy of Vaginal Progesterone in Reducing Preterm Birth in High-Risk Pregnancies
|
|
2020 |
|
|
|
|
[8]
|
Oral Micronized or Parenteral Progesterone versus Health Education in the Prevention of Preterm Birth: A Single Blinded Randomized Controlled Trial
|
|
2019 |
|
|
|
|
[9]
|
Assessment of efficacy of micronized progesterone by vaginal route for prevention of preterm labour
|
|
2019 |
|
|
|
|
[1]
|
Dynamic changes of views on the use of progesterone for the prevention of premature birth
Reproductive health of woman,
2024
DOI:10.30841/2708-8731.4.2024.308999
|
|
|
|
|
[2]
|
Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument against use
American Journal of Obstetrics & Gynecology MFM,
2024
DOI:10.1016/j.ajogmf.2024.101571
|
|
|
|
|
[3]
|
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
Journal of Perinatal Medicine,
2023
DOI:10.1515/jpm-2022-0462
|
|
|
|
|
[4]
|
Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.07.054
|
|
|
|
|
[5]
|
Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.04.023
|
|
|
|